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The cancer care experiences of gay, lesbian and bisexual patients: A 
secondary analysis of data from the UK Cancer Patient Experience Survey. 
 
Abstract 
 
Understanding the effects of population diversity on cancer-related experiences is a 
priority in oncology care. Previous research demonstrates inequalities arising from 
variation in age, gender and ethnicity. Inequalities and sexual orientation remain 
underexplored. Here, we report, for the first time in the UK, a quantitative secondary 
analysis of the 2013 UK National Cancer Patient Experience Survey which contains 
70 questions on specific aspects of care, and six on overall care experiences. 68,737 
individuals responded, of whom 0.8% identified as lesbian, gay or bisexual. 
Controlling for age, gender and concurrent mental health comorbidity, logistic 
regression models applying post-estimate probability Wald tests explored response 
differences between heterosexual, bisexual and lesbian/gay respondents. Significant 
differences were found for 16 questions relating to: (a) a lack of patient-centred care 
and involvement in decision making, (b) a need for health professional training and 
revision of information resources to negate the effects of heteronormativity, and (c) 
evidence of substantial social isolation through cancer. These findings suggest a 
pattern of inequality, with less positive cancer experiences reported by lesbian, gay 
and (especially) bisexual respondents. Poor patient-professional communication and 
heteronormativity in the healthcare setting potentially explain many of the differences 
found. Social isolation is problematic for this group and warrants further exploration. 
 
 
Keywords: Cancer, Oncology, Health Surveys, Equality, Sexual Orientation, Patient 
Experience 
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Introduction 
 
Across all aspects of cancer care, there is an important drive to explore the effects of 
population diversity. Recent work has demonstrated inequalities in the patient-
reported experience arising from variation in age, gender (Din et al, 2015) and 
ethnicity (Naylor, Ward & Polite, 2012). Far less is known about the impact of sexual 
orientation on cancer care experiences (Quinn et al 2015). The differential 
experiences of lesbian, gay and bisexual (LGB) cancer patients is important to 
understand, not least because this group is at increased risk of specific cancers. Pre-
menopausal lesbian and bisexual women have higher risk of breast, cervical, ovarian 
and lung cancers compared to heterosexual women (Boehmer et al, 2012; Clavelle 
et al, 2015) and gay men are at increased risk of anal cancer beyond that risk 
observed in heterosexual men (Chin-Hong et al, 2005; Goldstone et al, 2011). 
Overall, gay men are reported to be 1.9 times more likely to have cancer over their 
lifetime compared with heterosexual men (Boehmer, Miao & Ozonoff, 2011).  Much 
of this increased risk is likely due to lifestyle and health behaviour factors, such as 
alcohol use and smoking (Hagger-Johnson et al, 2013). 
 
Sexual orientation data is not routinely collected in either clinical practice or research 
(Kamen et al, 2015): this results in very little knowledge about how sexuality impacts 
cancer outcomes or experiences of care. A recent scoping review (Semlyen & 
Hulbert-Williams, 2013) summarised existing literature demontrating that LGB 
patients, when compared to heterosexuals, report poorer quality of life, anxiety and 
depression (Boehmer et al, 2011; Boehmer, Glickman & Winter, 2012) and more 
negative experiences of care and support during treatment (Matthews et al, 2012) 
but found a dearth of information on experiences of survivorship care.  A more recent 
study partly addresses cancer survivorship, reporting a disparity in psychological 
distress in gay men compared to heterosexual men (Kamen et al, 2014). The 
PDMRULW\RIFXUUHQWNQRZOHGJHIRFXVHVRQOHVELDQRUJD\SHRSOH¶VH[SHULHQFHVRI
cancer, and few studies explore the needs or experiences of bisexual patients; 
whether this results from a lack of dedicated funding, insufficient expertise or interest 
within oncology research, or that previous attempts to undertake work with bisexual 
patients has failed to produce publishable results (for example, failure to identify and 
recruit sufficient participant numbers) is unclear. Regardless, comparative research 
of the experiences of all groups of sexual orientation is essential to identify and 
address cancer care inequality. 
 
Large scale research in this area is sparce and secondary analysis of large datasets 
may be useful. One recent example of this describes sexual orientation inequality in 
psychological distress resulting from cancer in a large US dataset (Kamen et al, 
2015). The authors highlight important differences in distress based on the 
intersection of sexual orientation and gender, and that differences in support 
perceived as being available to different demographic sub-sets of patients may be an 
overall explanatory factor in predicting distress levels.  
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The UK National Cancer Patient Experience Survey (NCPES1) lends itself to a 
similar secondary analysis of UK cancer experiences.  Distributed annually to 
patients who receive cancer treatment in the UK, results are used to explore service 
provision differences and track quality improvement over time. Although differences 
in relation to sexual orientation were initially explored in the 2013 National Report 
(Quality Health, 2013) this did not statistically control for potentially confounding 
variables and grouped participants in such a way that makes interpretation of results 
difficult.  
 
This paper reports a more rigorous secondary analysis of the 2013 NCPES data, 
aiming to understand how the experiences of LGB patients with cancer differ from 
those of heterosexual patients. There are inherent problems with using secondary 
data, most notably including the small numbers identifying as LGB, and issues 
pertaining to the wording of specific questions: these will be discussed in detail later 
in this paper. The NCPES is, however, the largest dataset of cancer experience that 
enables analysis of this type and despite methodological and sampling limitations 
thus provides a valuable resource for exploratory analysis in this under-researched 
field. We adopt an epistemologically explorative stance; our intention is to highlight 
areas of potential inequality to inform future research. This analysis is the first of its 
kind within the UK cancer context. 
 
 
Methods 
The NCPES contains 72 self-report questions about cancer care: 66 focus on 
specific areas of care (e.g. interaction with healthcare professionals, provision of 
information etc.) and six focus on overall experiences. Nine demographic questions 
are asked, including one on sexual orientation. The survey was conducted by Quality 
Health and responses are matched to electronic hospital records for accurate clinical 
information. We used data from the 2013 survey: this was sent out to patients who 
received cancer treatment between 1st September and 20th November 2012.  Ethical 
approval for the original survey (including later secondary uses of the data) was 
obtained by Quality Health from the Ethics and Confidentiality Committee of the 
National Information Governance Board (Ref: ECC 6-02(FT4)/2012).  Data from the 
survey were deposited to the UK Data Service under End User Licence (EUL) 
Conditions (Department of Health, 2013); following registration with the UK Data 
Service we were permitted to download the data for secondary analysis. 
                                                          
1 Readers wishing to know more about development and administration of the NCPES are 
referred to the Quality Health website: https://www.quality-health.co.uk/surveys/national-
cancer-patient-experience-survey 
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Participants 
The 68,737 survey respondents represented a 64% response rate. 53% were 
female, 63% were retired, and their mean age was 66.3 years (SD=12.36). 96% 
identified as white-British indicating under representation of black and minority ethnic 
populations. 66% of respondents were within the first year since diagnosis.  Although 
all cancer sites were represented, 49% were diagnosed with one of the four most 
common cancers in the UK (breast, colorectal/lower gastro-intestinal, prostate, lung).  
Sexual orientation was detHUPLQHGE\UHVSRQVHWRWKHTXHVWLRQ³:KLFKRIWKH
IROORZLQJEHVWGHVFULEHV\RXUVH[XDORULHQWDWLRQ"´RIUHVSRQGHQWVLGHQWLILHG
as heterosexual/straight; 425 (0.6%) identified as lesbian or gay; 143 (0.2%) 
identified as bisexual; 0.9% of respondents FKRVHµRWKHU¶; and 3% indicated a 
preference not to answer.  A further 6% left the question blank. The small numbers 
identifying as LGB are unlikely to represent accurate population proportions of these 
sexual identities in the UK. The British National Survey of Sexual Attitudes and 
Lifestyles (NATSAL) for example, reported that 2.5% of men, and 2.4% of women 
self-identify as LGB, and an increasing number of both men and women report 
engaging in same-sex sexual behaviour (Mercer et al, 2013). Though we can only 
speculate on reasons for this, it is likely that this reflects an ongoing unwillingness to 
disclose sexual orientation in the context of the NCPES, which is compounded by 
the older mean age of the overall sample. A full sociodemographic and clinical 
comparison table of respondents to the NCPES used for this secondary analysis can 
be viewed in table 1. 
 
***INSERT TABLE 1 ABOUT HERE*** 
 
Analysis 
Sexual orientation was operationalised as three categories: heterosexual, bisexual, 
and lesbian/gay. Though an argument could be made to group the participants 
differently, our choice was informed by three considerations.  First, it allowed a 
cleaner disambiguation between gender and sexual orientation: had we, for 
example, analysed lesbian and gay respondents separately we would not 
necessarily know whether the differences were a result of sexual orientation or 
gender differences unless we had also split the heterosexual and bisexual group in 
the same way.  With such low participant numbers in the LGB groups already, further 
fragmentation would have reduced statistical power and increased the potential for 
Type I error; this was our second consideration.  Instead, a more statistically rigorous 
approach was to test and control for the confounding effects of gender (and other 
demographic variables) across the entire sample; had we split the lesbian and gay 
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group by gender and made a gender-based statistical control, we would be 
accounting for the effects of gender twice in some participant groups, but only once 
in the others which would be inappropriate. Power could have been increased further 
by merging lesbian, gay and bisexual into one category, however we had no strong a 
priori reasoning for assuming the experiences of bisexual and lesbian and gay 
participants would be similar enough to be grouped in this way; indeed, our results 
support this decision by finding clear differences between the two groups. Finally, it 
maintained participant grouping as defined by the participants themselves in 
response to the sexual orientation question on the survey.  
7KRVHZKRUHVSRQGHGµRWKHU¶RUZKRLQGLFDWHGDSUHIHUHQFHQRWWRDQVZHUZHUHQRW
included in the analysis. Whilst no explicit assumption is made about the type of 
missing data, it is unlikely that it occurs randomly in all cases; we thus did not impute 
sexuality to avoid adding bias. 
 
Multinomial logistic regression (with sexual orientation as the dependent variable) 
was used to identify socio-demographic and clinical confounders. Gender, age, and 
concurrent mental health comorbidity were each statistically significant in predicting 
the likelihood of sexual orientation (three categories: heterosexual, lesbian and gay, 
bisexual), and so were selected as independent variables for later analyses. Level of 
education, ethnicity and physical health co-morbidities were not significant and so 
were not included in the later analyses. We were unable to account for differences in 
cancer type or treatment due to small sub-group sizes in the lesbian/gay and 
bisexual groups.  
 
Logistic regression analyses were performed for each question with sexual 
orientation, gender, age and concurrent mental health comorbidity forced into each 
model as independent variables. Questions with multiple response options were 
analysed using ordinal or multinomial logistic regression, depending on whether 
categories had a natural ordering.  The significance of differences in response by 
category of sexual orientation were explored, applying post-estimation probabilities 
using Wald tests.  Wald tests are based upon the estimated variance-covariance 
matrix of estimators and are asymptotically equivalent to likelihood ratio tests. 
However, they have the advantage of requiring only one model, thus offering a 
pragmatic alternative in the case of multiple analyses (Long & Freese, 2006). 
Analyses were performed in Stata 13. 
We explored differences in responses to all questions except for question 66 (Have 
you had treatment from any of the following for your cancer? Response options: 
physiotherapist, occupational therapist, dietician, speech and language therapist, 
lymphoedema specialist) as data here was recorded only if patients answered in the 
affirmative. As a result, positive response rates varied considerably (9% to 38%) 
across each category. It is unsafe to assume that where participants left this 
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question blank that this corresponded to a negative response, and as such the data 
could not be considered robust. 
We employed an exploratory rather than hypotheses-driven approach to analysis 
(Grove & Andreasen, 1982) adopting a standard alpha level of 0.05 for statistical 
significance, but without making any adjustment (e.g. Bonferroni Correction) for 
multiple testing; such corrections are used to reduce probability of Type I error but as 
we had no a priori hypotheses this was not relevant to our study aim. 
 
Results 
Complete data was available for sexual orientation and control variables for 57,402 
respondents; the remaining 16% of participants were excluded from this analysis. In 
16 of 69 questions analysed, sexual orientation was a significant predictor of 
response (at p<0.05). These are summarised in Table 2; this should be cross-
referenced with Figure 1 which shows between-group comparison.  
 
***INSERT TABLE 2 ABOUT HERE*** 
 
Wald test results indicate for which questions an overall significant difference in 
response exists across categories of sexual orientation ± statistical significance for 
these tests is included in parentheses in the summary of results which follows. For 
these questions we explored post-estimation probabilities of differences between 
each sexual orientation category (see Figure 1). Below, we report on questions in 
which post-estimation results for sexual orientation categories were significant 
(p<0.05; for full results, see supplementary material.) 
 
***INSERT FIGURE 1 ABOUT HERE*** 
 
Questions about cancer diagnosis 
Bisexual respondents were significantly less likely to report that they had had a 
diagnostic test for cancer within the previous 12 months (p=.03). They were also 
more likely to respond that they were told by a nurse or other healthcare professional 
(than a doctor) that they had cancer, and significantly less likely to have received this 
information through lay-referral (via friend or relative) than other sexual orientation 
participant categories (p=.03). When asked whether they had been given any written 
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LQIRUPDWLRQDWGLDJQRVLVELVH[XDOUHVSRQGHQWVZHUHPRUHOLNHO\WRUHVSRQG³<HVEXW
LWZDVGLIILFXOWWRXQGHUVWDQG´p=.01). 
Questions about treatment decisions  
Bisexual respondents were more likely to report that they would have liked a choice 
of treatment option but were not offered one, and lesbian/gay respondents more 
frequently responded that that were not given a choice because there was only one 
suitable treatment type available (p<.01). Bisexual respondents reported that they 
were not as involved as much as they would have liked to have been in decisions 
about their care and treatment (p<.01), and that they were not given written 
information about side-effects of treatments; lesbian/gay respondents more 
frequently responded that they received this information, but that it was difficult to 
understand (p=.01). 
Questions about relationships with healthcare professionals 
When asked about their relationships with healthcare professionals, bisexual 
respondents were more likely to indicate that it was difficult to contact their nurse 
specialist (p<.01), and that they got understandable answers to important questions 
RQO\³VRPHRIWKHWLPH´p=.01). A higher proportion of bisexual respondents 
indicated that ward nurses talked in front of them as if they were not there (p=.02). In 
UHVSRQVHWRWKHTXHVWLRQ³If your family or someone else close to you wanted to talk 
WRDGRFWRUGLGWKH\KDYHHQRXJKRSSRUWXQLW\WRGRVR"´a higher proportion of both 
lesbian/gay and bisexual respondents indicated that either no family or friends were 
involved, or that they did not want their family or friends involved, compared with 
heterosexual respondents (p<.01). That is, the difference was not one of a lack of 
RSSRUWXQLW\SURYLGHGWRWDONWRGRFWRUVEXWUDWKHUWKDWWKHUHZDVQ¶WDVLJQLILFDQW
person involved to take up such opportunity. 
Questions about care after treatment had finished 
During aftercare, bisexual respondents were less likely to report they had been given 
enough care and help from health and social services (p=.03), and reported that 
KRVSLWDOVWDIIGLGHYHU\WKLQJSRVVLEOHWRFRQWUROUDGLRWKHUDS\VLGHHIIHFWV³RQO\WR
VRPHH[WHQW´p=.05). Lesbian/gay respondents were less likely than both 
heterosexuals and bisexuals to have received a written care or assessment plan 
(p=.02). Once again, when asked whether family or those close to them were given 
all the information they required regarding home care, LGB respondents were more 
likely to have replied that either no family or friends were involved, or that they did 
not want their family or friends involved (p<.01). 
Questions about psychosocial support and overall care 
Lesbian/gay respondents were more likely to indicate that they were not treated with 
dignity and respect through their cancer care (p=.01). When asked whether they felt 
Sexual orientation differences in cancer care 
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WKDWWKH\ZHUHWUHDWHGDV³DVHWRIV\PSWRPV´UDWKHUWKDQDZKROHSHUVRQELVH[XDO
UHVSRQGHQWVZHUHPRUHOLNHO\WRUHVSRQG³\HVRIWHQ´p=.01). 
 
 
 
Discussion 
This study offers an important contribution to understanding the cancer experiences 
of a marginalised socio-demographic group. In undertaking a large-scale secondary 
analysis of a substantial nationally-administered survey of cancer patient 
experiences, we build on the findings reported by Kamen et al (2015); secondary 
analysis of this type ensures that our findings are not limited by design 
considerations or specific sociodemographic or clinical inclusion criteria.  
Contextualising the findings 
Provision and utilization of healthcare services amongst LGB people are affected by 
the specific legislative and socio-cultural framework in each country (Quinn et al, 
2015). Given recent changes in the landscape for sexual equality in the UK (for 
example the inclusion of sexual orientation in equality and discrimination legislature 
(Equality Act, 2010) and the introduction of the Civil Partnership Act (2004) and so 
forth), it is both timely, and useful to explore potential inequality in cancer 
experiences in a UK sample. Despite the UK focus of our data, many findings have 
global implications, and are relevant especially in the context of the International 
Psycho-Oncology Society (IPOS) Lisbon Declaration (IPOS, 2014) which advocates 
quality psychosocial oncology care as a fundamental human right for all; empirical 
research that identifies and addresses inequality is essential achieving this goal. 
Consistent with broader literature (Boehmer et al, 2011; Kamen et al, 2015; Boehmer 
et al, 2012; Kamen et al, 2014), our findings suggest a pattern of inequalities in 
cancer care for LGB people, though where earlier studies focus on patient-reported 
outcome measures (e.g distress), ours focus on healthcare experiences; the findings 
are thus complementary and broaden our understanding of diversity in cancer care. 
This was especially true for bisexual respondents, a finding not so explicitly evident 
in previous research. For lesbian/gay respondents, specific aspects of care were 
often equivalent to heterosexual respondents. However, the experiences of lesbian 
and gay respondents mirror bisexual respondents on key themes related to patient-
centred care provision and social isolation, each of which remain of concern.  
The patterning of responses to the sexual orientation question on the NCPES 
highlight difficulties with the disclosure of sexual orientation This is likely to be 
reflected in face to face disclosure within healthcare consultations. Disclosing sexual 
orientation to healthcare providers is stressful (Kamen et al, 2015) and can result 
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from perceptions of heteronormativity and heterosexism (Irwin, 2007; Meyer, 2003), 
stigmatization (Whitehead, Shaver & Stephenson, 2015), discrimination (Elliott et al, 
2015; Quinn et al, 2015), fears of substandard treatment (Boehmer & Case, 2004), 
poor treatment of same-sex partners (Barbara, Quandt & Anderson, 2001), and 
heterosexist assumptions of sexual orientation (Hinchliff, Gott & Galena, 2005; 
Neville & Henrickson, 2006). This can affect numerous aspects of engagement and 
satisfaction with healthcare including utilization of services (Whitehead, Shaver & 
Stephenson, 2015), and poor communication (Morrison & Dinkel, 2012). 
Responses to the NCPES indicated a substantially greater number of significant 
differences in perception of cancer care experiences for bisexual respondents; 
greater even than for those identifying as lesbian or gay. Discrimination toward 
bisexual people (and indeed transsexual/ transgender communities) compared with 
lesbian and gay people in the UK has been slower to improve; marginalization 
comes from multiple sources, including from within the lesbian/gay community 
(Clarke et al, 2010). We postulate that a greater number of negative cancer care 
experiences reported by this group may be a consequence of this continued 
inequality, and lack of acceptance and understanding by wider society. Health issues 
such as cancer, may produce additional burden onto this already vulnerable group, 
and this needs to be better understood to enable intervention and service provision 
to adequately address these differences.  
Of course, there remains the possibility that the differences in experiences identified 
in this study are caused by unmeasured, tertiary variables. It is in some cases 
difficult to reconcile, for example, the extent of differences observed for a non-
disclosing bisexual cancer patients who may attend clinic with an opposite-sex 
partner. Even though in this case there may be no explicit prompt to disclose sexual 
orientation to a healthcare provider, there is indeed an implicit need to do so in order 
to ensure optimal patient-centred communication and care. The unwillingness to 
disclose on the part of the patient (as discussed above), combined with a lack of 
sexual orientation monitoring and questioning on the part of the healthcare provider, 
may well act as a substantial barrier to disclosure. Future research is clearly required 
to more fully explain differences in cancer experiences between those identifying as 
lesbian, gay and bisexual.  
Our specific findings orient around three central themes: 
1. Patient-centred care and shared decision making 
Bisexual respondents were significantly more likely to have reported that they were 
informed about their diagnosis by a nurse or other healthcare professional, but 
thereafter to have found it difficult to contact nurse specialists and to get 
understandable answers from them. They similarly reported that they were 
dissatisfied with their interaction with nurses on hospital wards, and the care and 
help provided by both health and social care services after leaving hospital. With a 
Sexual orientation differences in cancer care 
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focus on patient-centred holistic care, the nursing workforce remains one of the most 
important sources of support and care for cancer patients (Hulbert-Williams, 2016); 
previous research has demonstrated that nurse-led psychosocial care reduces 
distress (Lewis et al, 2009), and provides an effective model of follow-care (Swanson 
	.RFK7KDWWKLVZDVQ¶WWKHFDVHIRUELVH[XDOUHVSRQGHQWVLQWKLVVXUYH\LV
surprising and necessitates further empirical attention; this should be prioritised in 
future research.  
Despite wanting to be more involved in treatment decision-making, bisexual 
respondents indicated that they were not given a choice of treatments; similarly, 
lesbian/gay respondents indicated that they were informed that a choice of treatment 
was not available to them. This is an important finding given the global recognition of 
WKHLPSRUWDQFHRISDWLHQWDQGIULHQGVIDPLO\¶VLQYROYHPHQWLQKHDOWKFDUHGHFLVLRQ-
making. Irwin suggests that this discrepancy exists for LGB people as a direct result 
of homophobia and heterosexism (Irwin, 2007) but does not offer a causal 
explanation. Our findings confirm the continuation of these inequalities in the UK 
cancer care context.  
2. Implicit inequality via heteronormativity in information provision 
LGB respondents significantly differed from heterosexual respondents in their 
satisfaction with written information provided at diagnosis, treatment and aftercare. 
Broader literature suggests that perceived discrimination can arise where outward 
behaviour does not differ, but instead by omission. Typical communication strategies 
and information resources, whilst not explicitly homophobic, can perpetuate 
heteronormativity. Conversational micro-cues (Kitzinger, 2005a; Kitzinger, 2005b) 
and an over-reliance on heterosexual imagery (Blank, 2005), can create an implicit 
exclusionary context, leading to low levels of satisfaction. Sexual orientation equality 
is not necessarily about treating all people the same, but matching care to individual 
needs for all patients regardless of sexual orientation (Quinn et al, 2015), and this 
GRHVQ¶WVHHPWRKDYHEHHQWKHFDVHZLWKUHVSHFWWRWKHVHVSHFLILFFDQFHUFDUH
experiences. 
3.  Social Isolation 
This tacit exclusionary context becomes more problematic when considering that 
LGB respondents either do not have, or are choosing to exclude, significant others 
IURPWKHLUFDQFHUH[SHULHQFH,WLVXQIRUWXQDWHWKDWWKHVXUYH\GLGQ¶WLQFOXGHD
question on relationship status as this may have helped to further understand 
responses to these questions and to better contextualise the findings against Kamen 
HWDO¶V86GDWD.DPHQHWDO7KLVILQGLQJLVQRWXQLTXHWRFDQFHUFDUH²for  
LGB patients with dementia, the main source of informal care is not usually provided 
by family, with reliance instead on friends (Peel & McDaid, 2015)²and has been 
explained elsewhere as a deliberate strategy to protect family and friends from 
negative consequences of homophobia and heteronormativity (Barbara, Quandt & 
Sexual orientation differences in cancer care 
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Anderson, 2001); the same may well be true in the cancer context. All patients 
should be entitled to choose the degree of involvement of their loved ones (friends or 
family) in their care, but if that process involves sexual orientation disclosure, it is 
possible that choosing to exclude them may be regarded as a safer option. This 
paints a worrying picture of continued social isolation through cancer as previously 
UHSRUWHG*URVVPDQ'¶$XJHOOL	+HUVKEHUJHU 
Study evaluation 
There are limitations to our analyses, many of which are common to secondary 
analysis methodology. First, findings are based on only a small and disproportionate 
sub-sample of those identifying as LGB. Whilst gender has been identified as an 
important covariate in understanding sexual orientation cancer care experience 
(Kamen et al, 2015), we chose to maintain lesbian and gay respondents as a single 
category (statistically controlling for gender effects); this method not only matched 
the response options from the original survey but also increased statistical power for 
comparison analysis.  However in doing so we admittedly lose the distinct 
experiences of these discrete groups.  
1RWLQFOXGLQJELVH[XDODQGµRWKHU¶UHVSRQGHQWVLQWRWKLVVDPHFDWHJRU\UHIOHFWVD
pragmatic attempt to minimise further dilution of findings. Whilst there were sufficient 
numbers to gain meaningful insight into the experiences of bisexual repondents, the 
gURXSVL]HIRUWKHµRWKHU¶FDWHJRU\ZDVWRRVPDOOIRUDQDO\VLV&KRRVLQJµRWKHU¶LV
KRZHYHUDPHDQLQJIXOUHVSRQVHFKRLFHUDWKHUWKDQ³SUHIHUQRWWRVD\´LWVXJJHVWV
a sexual orientation that cannot neatly be defined by heterosexual, gay, lesbian or 
bisexual (for example asexual, pansexual, sexually fluid and so forth). A recent 
publication reports that levels of common mental disorder symptoms (e.g. 
GHSUHVVLRQDQ[LHW\LQLQGLYLGXDOVLGHQWLI\LQJDVµRWKHU¶DUHPRUHVLPLODUWRWKRVH
identifying as LGB than they are to heterosexuals (Semlyen et al, 2016). It is 
reasonable to ask, therefore, whether this shared non-heterosexual identity will 
impact on other aspects of life, and whether their cancer care experiences too may 
be poorer than those of heterosexual respondents. There is clearly more work to be 
done on understanding the cancer care experiences in those identifying as non-
heterosexual or LGB, thus highlighting a further important question for future 
research.  
Similarly, missing sexual orientation data was problematic: other studies have 
suggested that LGB people more often refuse to disclose sexual orientation (Ellison 
& Gunstone, 2009) and so the high proportion of missing data here is likely 
representative of the experiences of a broader group of non-disclosing LGB cancer 
patients. The combined effects of missing data on sexual orientation and statistical 
control variables resulted in 16% respondent exclusion which is an unavoidable 
limitation. If we were to make recommendations for future iterations of the NCPES, 
we would suggest that response options to the question on sexual orientation be re-
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considered to ensure that the data gathered is both more meaningful and usable in 
data analysis. 
A particular strength of our study is that we did not limit our analysis to a particular 
sociodemographic or clinical subgroup. We undertook a statistically robust approach 
to identifying sociodemographic and clinical confounding variables (ruling out some 
expected confounders, such as ethnicity (Naylor, Ward & Polite, 2012)) and we 
corrected for these as appropriate in comparative analysis. This is especially 
important in the case of age; older LGB individuals are likely to have a longer history 
of experiencing homophobia than younger generations. This is likely to affect 
interaction with healthcare professionals which in turn may have affected care 
experiences.  
Specific wording of some questions is problematic but something we had little control 
over; whilst it is important to consider the findings with appropriate caution we do not 
think this undermines the key findings from our work± our aim was exploratory and in 
that context we identify important areas of future study.  We nonetheless urge those 
who may replicate this survey to consider nuanced language: some questions have 
ambiguous and vague wording; others, for example the question about time to first 
appointment, are not compliant with good practice guidelines (in this case, the 
Aarhus Statement (Weller et al, 2012)).  There are known differences between self-
reported sexual orientation and sexual practice (Mercer et al, 2013) and so asking 
about sexual attraction and behaviour would be useful (Joloza et al, 2010) as would 
directly asking whether respondents feel that their sexual orientation impacted on 
cancer experiences.  
 
Finally, it is important to note that this work undertakes a secondary analysis of 
health service evaluation questionnaire rather than any validated psychometric tools. 
As such it has not been exposed to rigorous validity testing. We would caution 
readers to bear this in mind when considering the implications of the findings. 
 
Implications of the findings 
Retrospective self-report data has multiple methodological pitfalls. Not least, survey 
questions ask about what individuals remember and report, not what actually 
happened. It may be that there was no real difference in the care and support 
provided to LGB patients, but that they remember or evaluate it somehow differently, 
for known or unknown reasons.  Even if the differences are perceptual rather than 
behavioural, however, this may indicate a lack of bi-directional understanding 
between patient and healthcare professionals, and that has important clinical 
implications. In the context of the varied range of differences found in this analysis, it 
is understandable why lesbian/gay and bisexual respondents differed in their 
SHUFHSWLRQVRIKRZPXFKWKH\ZHUHWUHDWHGZLWK³GLJQLW\DQGUHVSHFW´DQG³DVDVHW
RIV\PSWRPVUDWKHUWKDQDZKROHSHUVRQ´ 
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These differences may relate to communication (both direct and implicit; written and 
verbal) between patients and healthcare teams. More explicit opportunity is needed 
to facilitate disclosure of sexual orientation to lower consequent burden during times 
of crisis, such as cancer diagnosis (Boehmer & Case, 2004). This perceived burden 
can be reduced with approaches that reduce perceptions of heteronormativity and 
implicit discrimination. Previous research advocates a need for more training to 
support healthcare professionals in providing cancer care to sexual minority groups 
.DPHQHWDO5H\JDQ	'¶$OWRQDQGRXUILQGLQJVDGGIXUWKHUZHLJKWWR
this. Such training may be beneficial in creating an environment in which comfortable 
communication exists (Klitzman & Greenberg, 2002) and where psychosocial 
support needs can be understood and met (Hinchliff, Gott & Galena, 2005) 
Furthering opportunities to acknowledge and discuss non-normative family dynamics 
and more inclusionary practice toward the acceptability of non-traditional modes of 
caring and support should be recognised, and may provide appropriate outcomes for 
staff training and development (Harding, Epiphaniou & Chidgley-Clark, 2012).  
 
Efforts to standardise monitoring of sexual orientation within healthcare and research 
are important to enable on-going analysis of, and opportunities to address, health 
inequalities (Kamen et al, 2015). On the basis of this study, and where it sits within a 
broader context of LGB research in cancer, a number of question still remain. A 
programme of mixed methods, interdisciplinary research is needed to empirically 
examine the varied issues raised within this paper. 
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Table 1:  Summary sociodemographic and clinical description for heterosexual, lesbian/gay and 
bisexual sub-samples 
  Heterosexual  
(N = 61,398) 
Lesbian/Gay 
(N = 425) 
Bisexual 
(N = 143) 
Age Mean (SD) 66 (12.3) 57.5 (13.4) 64 (14.9) 
Gender N (%)    
 Female 32,485 (52.9) 173 (40.7) 62 (43.4) 
 Male 28,913 (47.1) 252 (59.3) 81 (56.6) 
Ethnicity N (%)    
 British / Irish 57,342 (99.1) 379 (0.7) 121 (0.2) 
 Other White 1,118 (97.9) 20 (1.8) 4 (0.35) 
 Other  2,174 (98.7) 18 (0.8) 11 (0.5) 
Time since diagnosis N (%)    
 < 1 year 40,051 (66.2) 286 (67.8) 83 (61) 
 1-5 years 15,128 (25.0) 112 (26.5) 37 (27) 
 > 5 years 5,138 (8.5) 24 (5.7) 15 (11.0) 
 ŽŶ ?ƚŬŶŽǁ ?ĐĂŶ ?ƚƌĞŵĞŵďĞƌ 165 (0.3) 0 (0.0) 2 (1.5) 
Employment N (%)    
 Full time 10,299 (17.0) 142 (33.7) 30 (21.3) 
 Part time 5,566 (9.2) 38 (9.0) 17 (12.1) 
 Homemaker 1,698 (2.8) 4 (1.0) 3 (2.1) 
 Student  162 (0.3) 6 (1.4) 1 (0.7) 
 Retired 37,740 (62.4) 148 (35.1) 72 (51.1) 
 Unemployed (seeking) 414 (0.7) 9 (2.1) 1 (0.7) 
 Unemployed (health) 3,392 (5.6) 60 (14.2) 12 (8.5) 
 Other 1,263 (2.1) 15 (3.6) 5 (3.6) 
Comorbidities N    
 Deafness 6,267 (10.9) 32 (8.0) 19 (14.0) 
 Blindness 1,378 (2.39) 3 (0.8) 3 (2.2) 
 Physical disability 8,329 (14.5) 53 (13.2) 21 (15.4) 
 Learning disability 222 (0.39) 2 (0.5) 2 (1.5) 
 Mental health 1,188 (2.06) 33 (8.2) 8 (5.9) 
 Long standing illness 8,108 (14.1) 74 (18.5) 22 (16.2) 
 None 37,455 (65.1) 244 (61.0) 76 (55.9) 
Comorbidities Mean (SD) 0.4427 (0.6681) 0.4913 (0.6786) 0.5515 (0.6973) 
Ethnicity N (%)    
 British 56,524 (93.2) 370 (88.7) 117 (86.0) 
 Irish 818 (1.4) 9 (2.2) 4 (2.9) 
 Other White 1,118 (1.8) 20 (4.8) 4 (2.9) 
 White & Black Caribbean 77 (0.1) 2 (0.5) 1 (0.7) 
 White & Black African 29 (0.1) 2 (0.5) 0 (0.0) 
 White & Asian 86 (0.1) 0 (0.0) 0 (0.0) 
 Other mixed 70 (0.1) 4 (0.1) 1 (0.7) 
 Asian 477 (0.8) 2 (0.5) 4 (2.9) 
 Pakistani 179 (0.3) 1 (0.2) 1 (0.7) 
 Bangladeshi 49 (0.1) 0 (0.0) 0 (0.0) 
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 Other Asian 205 (0.3) 1 (0.2) 1 (0.7) 
 Caribbean 438 (0.7) 3 (0.7) 1 (0.7) 
 African 286 (0.5) 1 (0.2) 2 (1.5) 
 Other black 35 (0.1) 0 (0.0) 0 (0.0) 
 Chinese 151 (0.3) 1 (0.2) 0 (0.0) 
 Other 92 (0.2) 1 (0.2) 0 (0.0) 
Tumour Group    
 Brain/Central Nervous System 663 2 7 
 Breast 12,601 23 71 
 Colorectal / Lower  Gastrointestinal 7,894 14 61 
 Gynaecological 3,436 8 26 
 Haematological 10,341 35 73 
 Head and Neck 2,177 7 18 
 Lung 4,431 4 29 
 Other 2,465 3 17 
 Prostate 5,045 18 38 
 Sarcoma 629 0 14 
 Skin 1,662 4 11 
 Upper Gastrointestinal 3,834 8 28 
 Urological 6,220 17 32 
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Table 2. Logistical regression model summaries showing the significance of sexual 
orientation as a predictor of difference responses (note: includes only those 
significant at p<.05; full results are provided as supplementary material and question 
numbers included for cross reference; see table footnote for key to model type). 
Question Responses 
included in 
model (n)  
Wald test 
results of 
sexual 
orientation 
as a 
predictor 
฀2  P  
Questions about cancer diagnosis 
 In the last 12 months have you had diagnostic 
test(s) for cancer at one of the hospitals named in 
the covering letter? 
562951 7.19 0.03 
 Who first told you that you had cancer? 570173 20.15 0.03 
 When you were told you had cancer, were you 
given written information about the type of cancer 
you had? 
574653 17.48 0.01 
Questions about treatment decisions 
 Before your cancer treatment started, were you 
given a choice of different types of treatment? 
554653 27.24 <0.01 
 Before you started your treatment, were you given 
written information about the side effects of 
treatment(s)? 
531763 13.93 0.01 
 Were you involved as much as you wanted in 
decision about your care and treatment? 
554042 11.50 <0.01 
Questions about relationships with healthcare professionals 
 How easy is it for you to contact your nurse 
specialist? 
482263 19.68 <0.01 
 When you have important questions to ask your 
clinical nurse specialist, how often do you get 
answers you can understand? 
470503 18.17 0.01 
 Did ward nurses talk LQIURQWRI\RXDVLI\RXZHUHQ¶W
there? 
386962 8.31 0.02 
 If your family or someone else close to you wanted 
to talk to a doctor, did they have enough 
opportunity to do so? 
389363 63.59 <0.01 
Questions about care after treatment had finished 
 After leaving hospital, were you given enough care 
and help from health and social services? 
382343 13.96 0.03 
 Did hospital staff do everything possible to control 
the side effects of radiotherapy? 
538393 15.68 0.05 
 Have you been offered a written assessment and 
care plan? 
482141 8.20 0.02 
 Did the doctors or nurses give your family or 
someone close to you all the information they 
needed to help care for you at home? 
382673 61.93 <0.01 
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Questions about psychosocial support and overall care 
 Were you treated with dignity and respect by the 
doctors and nurses and other hospital staff? 
386522 8.53 0.01 
 Sometimes people with cancer feel they are treated 
DV³DVHWRIV\PSWRPV´UDWKHUWKDQDZKROHSHUVRQ
In your NHS care over the last year did you feel like 
that? 
 
 
567782 
9.55 0.01 
1logistic regression; 2ordered logistic regression; 3multinomial logistic regression
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Figure 1. Between group comparisons in response likelihood for those questions reaching p<.01 significance in Wald tests. 
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Questions about treatment decisions 
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Diagnostic tests in last 12 months?
Yes No
0 0.5 1
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L/G
Hospital Dr Hospital nurse GP
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Who first told you that you had cancer?
0 0.5 1
H
B
L/G
Easy to understand Difficult to understand
None Not needed
Were you given written information at 
diagnosis?
0 0.5 1
H
B
L/G
Yes No Only one suitable
Were you given a choice of different types of 
treatment?
0 0.5 1
H
B
L/G
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Were you involved as much as you wanted in 
decision about your care and treatment?
0 0.5 1
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Questions about relationships with healthcare professionals 
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Did your family or those close to you have the 
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ƚƌĞĂƚĞĚĂƐ ?ĂƐĞƚŽĨƐǇŵƉƚŽŵƐ ?ƌĂƚŚĞƌƚŚĂŶĂ
whole person. Did you feel that?
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Supplementary table:  Results of statistical analysis of difference in response by sexual identity category for all questions in the 
patient experience survey. 
 
Question Respons
es 
included 
in model 
(n) 
Model post estimation: 
Wald test results of 
sexuality (L/G, B, H) as a 
predictor 
฀2  P  
1: Before you were told you needed to go to the hospital about cancer, how many 
times did you see your GP (family doctor) about the health problem cause by 
cancer? 
56044 7.71 0.46 
2: How do you feel about the length of time you had to wait before your first 
appointment with a hospital doctor? 
56656 1.81 0.40 
3: How long was it from the time you first thought something might be wrong with 
you until you first saw a hospital doctor? 
54978  3.05 0.22 
4: Did your health get worse, get better or stay about the same while you were 
waiting for your first appointment with a hospital doctor? 
56551 1.73 0.42 
5: In the last 12 months, have you had diagnostic test(s) for cancer such as an 
endoscopy, biopsy, mammogram, or scan at one of the hospitals named in the 
covering letter? 
56295 7.19 0.03 
6: Beforehand, did a member of staff explain the purpose of the test? 50395 11.31 0.08 
7: Beforehand, did a member of staff explain what would be done during the test 
procedure(s)? 
50629 4.33 0.63 
8: Beforehand, were you given written information about your test(s)? 47560 2.82 0.83 
9: Were the results of the test(s) explained in a way you could understand? 50598 5.07 0.53 
10: Who first told you that you had cancer? 57017 20.15 0.03 
11: When you were first told that you had cancer, had you been told you could bring 
a family member or friend with you? 
54357 8.32 0.22 
12: How do you feel about the way you were told you had a cancer? 57397 3.43 0.18 
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13: Did you understand the explanation of what was wrong with you? 57420 2.09 0.72 
14: When you were told you had cancer, were you given written information about 
the type of cancer you had? 
54765 17.48 0.01 
15: Before your cancer treatment started, were you given a choice of different types 
of treatment? 
55465 27.24 <0.01 
16: Do you think your views were taken into account when the team of doctors and 
nurses caring for you were discussing which treatment you should have? 
53934 4.67 0.59 
17: Were the possible side effects of treatment(s) explained in a way you could 
understand? 
56255 9.36 0.15 
18: Before you started your treatment, were you given written information about the 
side effects of treatment(s)? 
53176 13.93 0.01 
19: Before you started your treatment, were you also told about any side effects of 
the treatment that could affect you in the future rather than straight away? 
53316 4.98 0.55 
20: Were you involved as much as you wanted to be in decisions about your care 
and treatment? 
55404 11.50 <0.01 
21: Were you given the name of a clinical nurse specialist who would be in charge 
of your care? 
54857 3.04 0.22 
22: How easy is it for you to contact your clinical nurse specialist? 48226 19.68 <0.01 
23: The last time you spoke to your clinical nurse specialist, did she/he listen 
carefully to you? 
46682 3.45 0.18 
24: When you have important questions to ask your clinical nurse specialist, how 
often do you get answers you can understand? 
47050 18.17 0.01 
25: Did hospital staff give you information about support or self-help groups for 
people with cancer? 
54092 9.15 0.06 
26: Did hospital staff discuss with you or give you information about the impact 
cancer could have on your work life or education? 
54447 5.62 0.23 
27: Did hospital staff give you information about how to get financial help or any 
benefits you might be entitled to? 
54929 1.39 0.85 
28: Did hospital staff tell you that you could get free prescriptions? 55643 6.96 0.14 
29: Have you seen information (such as leaflets, posters, information screens etc.) 
about cancer research in your hospital? 
56825 0.85 0.65 
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30: Since your diagnosis, has anyone discussed with you whether you would like to 
take part in cancer research? 
54107 0.40 0.82 
31: If yes, did you then go on to take part in cancer research? 172841 3.21 0.20 
32: During the last 12 months, have you had an operation (such as removal of a 
tumour or lump) at one of the hospitals named in the covering letter? 
57054 2.72 0.26 
33: Before you had your operation, did a member of staff explain what would be 
done during the operation? 
323732 2.11 0.91 
34: Beforehand, were you given written information about your operation? 3298662 8.04 0.10 
35: After the operation, did a member of staff explain how it had gone in a way you 
could understand? 
325262 6.17 0.40 
36: During the last 12 months, have you had an operation or stayed overnight for 
cancer care at one of the hospitals named in the covering letter? 
57001 0.84 0.66 
37: When you had important questions to ask a doctor, how often did you get 
answers that you could understand? 
39030 9.37 0.15 
38: Did you have confidence and trust in the doctors treating you? 39108 1.86 0.39 
'LGGRFWRUVWDONLQIURQWRI\RXDVLI\RXZHUHQ¶WWKHUH" 39037 4.83 0.09 
40: If your family or someone else close to you wanted to talk to a doctor, did they 
have enough opportunity to do so? 
38936 63.59 <0.01 
41: When you had important questions to ask a ward nurse, how often did you get 
answers you could understand? 
38944 8.88 0.18 
42: Did you have confidence and trust in the ward nurses treating you? 38989 0.20 0.91 
43: Did ZDUGQXUVHVWDONLQIURQWRI\RXDVLI\RXZHUHQ¶WWKHUH" 38696 8.31 0.02 
44: In your opinion, were there enough nurses on duty to care for you in hospital? 38720 2.33 0.31 
45: While you were in hospital did you ever think that the doctors or nurses were 
deliberately not telling you certain things that you wanted to know? 
38953 4.14 0.13 
46: While you were in hospital, did it ever happen that one doctor or nurse said one 
thing about your condition or treatment, and another said something different? 
38881 2.75 0.25 
47: While you were in hospital did the doctors and nurses ask you what name you 
prefer to be called by? 
38741 2.43 0.30 
48: Were you given enough privacy when discussing you condition or treatment? 39045 2.84 0.24 
49: Were you given enough privacy when being examined or treated? 39128 3.38 0.18 
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50: Were you able to discuss any worries or fears with staff during your hospital 
visit? 
39028 12.37 0.14 
51: Do you think the hospital staff did everything they could to help control your 
pain? 
38553 9.19 0.16 
52: Were you treated with respect and dignity by the doctors and nurses and other 
hospital staff? 
38652 8.53 0.01 
53: Were you given clear written information about what you should or should not do 
after leaving hospital? 
38492 3.66 0.45 
54: Did hospital staff tell you who to contact if you were worried about your condition 
or treatment after you left hospital? 
37464 0.09 0.96 
55: Did the doctors or nurses give your family or someone close to you all the 
information they needed to help care for you at home? 
38267 61.93 <0.01 
56: After leaving hospital, were you given enough care and help from health or 
social services (for example, district nurses, home helps, or physiotherapists)? 
38234 13.96 0.03 
57: Did hospital staff do everything possible to control the side effects of 
radiotherapy? 
53839 15.68 0.05 
58: Did hospital staff do everything possible to control the side effects of 
chemotherapy? 
54769 5.08 0.75 
59: While you were being treated as an outpatient or day case, did hospital staff do 
everything they could to help control your pain? 
54709 8.56 0.20 
60: Whilst you were being treated as an outpatient or day case, were you given 
enough emotional support from hospital staff? 
54759 1.59 0.95 
61: In the last 12 months, have you had an outpatients appointment with a cancer 
doctor at one of the hospitals named in the covering letter? 
56297 0.90 0.64 
62: The last time you had an appointment with a cancer doctor, did they have the 
right documents, such as medical notes, x-rays and test results? 
51896 0.32 0.85 
63: As far as you know, was your GP given enough information about yoru condition 
and the treatment you had at the hospital? 
46786 0.36 0.84 
64: Do you think the GPs and nurses at your general practice did everything they 
could to support you while you were having cancer treatment? 
56348 2.96 0.81 
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65: Did the different people treating and caring for you (such as GP, hospital 
doctors, hospital nurses, specialist nurses, community nurses) work well together to 
give you the best possible care? 
54508 3.78 0.88 
66: Have you had treatment from any of the following for your cancer? (tick all that 
apply) 
Not included in analysis of this dataset 
± see main text for explanation 
67: How much information were you given about your condition and treatment? 55973 3.09 0.21 
68: Have you been offered a written assessment and care plan? A care plan is a 
document that sets out your needs and goals for caring for your cancer. It is an 
agreement or plan between you and your health professional to help meet those 
goals. 
48214 8.20 0.02 
6RPHWLPHVSHRSOHZLWKFDQFHUIHHOWKH\DUHWUHDWHGDV³DVHWRIFDQFHU
V\PSWRPV´UDWKHUWKDQDZKROHSHUVRQ,Q\RXU1+6FDUHRYHUWKHODVW\HDUGLG\RX
feel like that? 
56778 9.55 0.01 
70: Overall, how would you rate your care. 57124 3.59 0.17 
 
1 >ŽǁĞƌƌĞƐƉŽŶƐĞƚŽƚŚŝƐƋƵĞƐƚŝŽŶďĞĐĂƵƐĞĐŽŵƉůĞƚŝŽŶǁĂƐŽŶůǇŶĞĐĞƐƐĂƌǇǁŚĞƌĞƉĂƌƚŝĐŝƉĂŶƚƐĂŶƐǁĞƌĞĚ ?ǇĞƐ ?ƚŽY ? ? ? 
2 Lower response rates as participants were only invited to complete these questions if they had answereĚ ?ǇĞƐ ?ƚŽY ? ? ? 
 
 
